Global Non-Invasive Prenatal Screening (NIPS) Market Research Report 2024(Status and Outlook)
Report Overview:
The Global Non-Invasive Prenatal Screening (NIPS) Market Size was estimated at USD 4175.01 million in 2023 and is projected to reach USD 7236.36 million by 2029, exhibiting a CAGR of 9.60% during the forecast period.
This report provides a deep insight into the global Non-Invasive Prenatal Screening (NIPS) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Non-Invasive Prenatal Screening (NIPS) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Non-Invasive Prenatal Screening (NIPS) market in any manner.
Global Non-Invasive Prenatal Screening (NIPS) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Myriad Genetics
Illumina
Progenity
Natera
Yourgene Health
Roche Sequencing Solutions (RSS)
Eurofins LifeCodexx GmbH
Labcorp
PerkinElmer
Harmony
Market Segmentation (by Type)
Trisomy 21
Trisomy 18
Trisomy 13
Sex Chromosome Aneuploidies
Others
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Non-Invasive Prenatal Screening (NIPS) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Non-Invasive Prenatal Screening (NIPS) Market Size was estimated at USD 4175.01 million in 2023 and is projected to reach USD 7236.36 million by 2029, exhibiting a CAGR of 9.60% during the forecast period.
This report provides a deep insight into the global Non-Invasive Prenatal Screening (NIPS) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Non-Invasive Prenatal Screening (NIPS) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Non-Invasive Prenatal Screening (NIPS) market in any manner.
Global Non-Invasive Prenatal Screening (NIPS) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Myriad Genetics
Illumina
Progenity
Natera
Yourgene Health
Roche Sequencing Solutions (RSS)
Eurofins LifeCodexx GmbH
Labcorp
PerkinElmer
Harmony
Market Segmentation (by Type)
Trisomy 21
Trisomy 18
Trisomy 13
Sex Chromosome Aneuploidies
Others
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Non-Invasive Prenatal Screening (NIPS) Market
- Overview of the regional outlook of the Non-Invasive Prenatal Screening (NIPS) Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Non-Invasive Prenatal Screening (NIPS) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Non-Invasive Prenatal Screening (NIPS)
1.2 Key Market Segments
1.2.1 Non-Invasive Prenatal Screening (NIPS) Segment by Type
1.2.2 Non-Invasive Prenatal Screening (NIPS) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET COMPETITIVE LANDSCAPE
3.1 Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Company (2019-2024)
3.2 Non-Invasive Prenatal Screening (NIPS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Non-Invasive Prenatal Screening (NIPS) Market Size Sites, Area Served, Product Type
3.4 Non-Invasive Prenatal Screening (NIPS) Market Competitive Situation and Trends
3.4.1 Non-Invasive Prenatal Screening (NIPS) Market Concentration Rate
3.4.2 Global 5 and 10 Largest Non-Invasive Prenatal Screening (NIPS) Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 NON-INVASIVE PRENATAL SCREENING (NIPS) VALUE CHAIN ANALYSIS
4.1 Non-Invasive Prenatal Screening (NIPS) Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2019-2024)
6.3 Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Type (2019-2024)
7 NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size (M USD) by Application (2019-2024)
7.3 Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Application (2019-2024)
8 NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET SEGMENTATION BY REGION
8.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region
8.1.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region
8.1.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region
8.2 North America
8.2.1 North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Non-Invasive Prenatal Screening (NIPS) Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Non-Invasive Prenatal Screening (NIPS) Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Myriad Genetics
9.1.1 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Basic Information
9.1.2 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Product Overview
9.1.3 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.1.4 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) SWOT Analysis
9.1.5 Myriad Genetics Business Overview
9.1.6 Myriad Genetics Recent Developments
9.2 Illumina
9.2.1 Illumina Non-Invasive Prenatal Screening (NIPS) Basic Information
9.2.2 Illumina Non-Invasive Prenatal Screening (NIPS) Product Overview
9.2.3 Illumina Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.2.4 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) SWOT Analysis
9.2.5 Illumina Business Overview
9.2.6 Illumina Recent Developments
9.3 Progenity
9.3.1 Progenity Non-Invasive Prenatal Screening (NIPS) Basic Information
9.3.2 Progenity Non-Invasive Prenatal Screening (NIPS) Product Overview
9.3.3 Progenity Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.3.4 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) SWOT Analysis
9.3.5 Progenity Business Overview
9.3.6 Progenity Recent Developments
9.4 Natera
9.4.1 Natera Non-Invasive Prenatal Screening (NIPS) Basic Information
9.4.2 Natera Non-Invasive Prenatal Screening (NIPS) Product Overview
9.4.3 Natera Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.4.4 Natera Business Overview
9.4.5 Natera Recent Developments
9.5 Yourgene Health
9.5.1 Yourgene Health Non-Invasive Prenatal Screening (NIPS) Basic Information
9.5.2 Yourgene Health Non-Invasive Prenatal Screening (NIPS) Product Overview
9.5.3 Yourgene Health Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.5.4 Yourgene Health Business Overview
9.5.5 Yourgene Health Recent Developments
9.6 Roche Sequencing Solutions (RSS)
9.6.1 Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Basic Information
9.6.2 Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Product Overview
9.6.3 Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.6.4 Roche Sequencing Solutions (RSS) Business Overview
9.6.5 Roche Sequencing Solutions (RSS) Recent Developments
9.7 Eurofins LifeCodexx GmbH
9.7.1 Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Basic Information
9.7.2 Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Product Overview
9.7.3 Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.7.4 Eurofins LifeCodexx GmbH Business Overview
9.7.5 Eurofins LifeCodexx GmbH Recent Developments
9.8 Labcorp
9.8.1 Labcorp Non-Invasive Prenatal Screening (NIPS) Basic Information
9.8.2 Labcorp Non-Invasive Prenatal Screening (NIPS) Product Overview
9.8.3 Labcorp Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.8.4 Labcorp Business Overview
9.8.5 Labcorp Recent Developments
9.9 PerkinElmer
9.9.1 PerkinElmer Non-Invasive Prenatal Screening (NIPS) Basic Information
9.9.2 PerkinElmer Non-Invasive Prenatal Screening (NIPS) Product Overview
9.9.3 PerkinElmer Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.9.4 PerkinElmer Business Overview
9.9.5 PerkinElmer Recent Developments
9.10 Harmony
9.10.1 Harmony Non-Invasive Prenatal Screening (NIPS) Basic Information
9.10.2 Harmony Non-Invasive Prenatal Screening (NIPS) Product Overview
9.10.3 Harmony Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.10.4 Harmony Business Overview
9.10.5 Harmony Recent Developments
10 NON-INVASIVE PRENATAL SCREENING (NIPS) REGIONAL MARKET FORECAST
10.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast
10.2 Global Non-Invasive Prenatal Screening (NIPS) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country
10.2.3 Asia Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Region
10.2.4 South America Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Non-Invasive Prenatal Screening (NIPS) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Non-Invasive Prenatal Screening (NIPS) Market Forecast by Type (2025-2030)
11.2 Global Non-Invasive Prenatal Screening (NIPS) Market Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Non-Invasive Prenatal Screening (NIPS)
1.2 Key Market Segments
1.2.1 Non-Invasive Prenatal Screening (NIPS) Segment by Type
1.2.2 Non-Invasive Prenatal Screening (NIPS) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET COMPETITIVE LANDSCAPE
3.1 Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Company (2019-2024)
3.2 Non-Invasive Prenatal Screening (NIPS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Non-Invasive Prenatal Screening (NIPS) Market Size Sites, Area Served, Product Type
3.4 Non-Invasive Prenatal Screening (NIPS) Market Competitive Situation and Trends
3.4.1 Non-Invasive Prenatal Screening (NIPS) Market Concentration Rate
3.4.2 Global 5 and 10 Largest Non-Invasive Prenatal Screening (NIPS) Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 NON-INVASIVE PRENATAL SCREENING (NIPS) VALUE CHAIN ANALYSIS
4.1 Non-Invasive Prenatal Screening (NIPS) Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2019-2024)
6.3 Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Type (2019-2024)
7 NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size (M USD) by Application (2019-2024)
7.3 Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Application (2019-2024)
8 NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET SEGMENTATION BY REGION
8.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region
8.1.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region
8.1.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region
8.2 North America
8.2.1 North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Non-Invasive Prenatal Screening (NIPS) Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Non-Invasive Prenatal Screening (NIPS) Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Myriad Genetics
9.1.1 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Basic Information
9.1.2 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Product Overview
9.1.3 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.1.4 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) SWOT Analysis
9.1.5 Myriad Genetics Business Overview
9.1.6 Myriad Genetics Recent Developments
9.2 Illumina
9.2.1 Illumina Non-Invasive Prenatal Screening (NIPS) Basic Information
9.2.2 Illumina Non-Invasive Prenatal Screening (NIPS) Product Overview
9.2.3 Illumina Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.2.4 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) SWOT Analysis
9.2.5 Illumina Business Overview
9.2.6 Illumina Recent Developments
9.3 Progenity
9.3.1 Progenity Non-Invasive Prenatal Screening (NIPS) Basic Information
9.3.2 Progenity Non-Invasive Prenatal Screening (NIPS) Product Overview
9.3.3 Progenity Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.3.4 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) SWOT Analysis
9.3.5 Progenity Business Overview
9.3.6 Progenity Recent Developments
9.4 Natera
9.4.1 Natera Non-Invasive Prenatal Screening (NIPS) Basic Information
9.4.2 Natera Non-Invasive Prenatal Screening (NIPS) Product Overview
9.4.3 Natera Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.4.4 Natera Business Overview
9.4.5 Natera Recent Developments
9.5 Yourgene Health
9.5.1 Yourgene Health Non-Invasive Prenatal Screening (NIPS) Basic Information
9.5.2 Yourgene Health Non-Invasive Prenatal Screening (NIPS) Product Overview
9.5.3 Yourgene Health Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.5.4 Yourgene Health Business Overview
9.5.5 Yourgene Health Recent Developments
9.6 Roche Sequencing Solutions (RSS)
9.6.1 Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Basic Information
9.6.2 Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Product Overview
9.6.3 Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.6.4 Roche Sequencing Solutions (RSS) Business Overview
9.6.5 Roche Sequencing Solutions (RSS) Recent Developments
9.7 Eurofins LifeCodexx GmbH
9.7.1 Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Basic Information
9.7.2 Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Product Overview
9.7.3 Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.7.4 Eurofins LifeCodexx GmbH Business Overview
9.7.5 Eurofins LifeCodexx GmbH Recent Developments
9.8 Labcorp
9.8.1 Labcorp Non-Invasive Prenatal Screening (NIPS) Basic Information
9.8.2 Labcorp Non-Invasive Prenatal Screening (NIPS) Product Overview
9.8.3 Labcorp Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.8.4 Labcorp Business Overview
9.8.5 Labcorp Recent Developments
9.9 PerkinElmer
9.9.1 PerkinElmer Non-Invasive Prenatal Screening (NIPS) Basic Information
9.9.2 PerkinElmer Non-Invasive Prenatal Screening (NIPS) Product Overview
9.9.3 PerkinElmer Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.9.4 PerkinElmer Business Overview
9.9.5 PerkinElmer Recent Developments
9.10 Harmony
9.10.1 Harmony Non-Invasive Prenatal Screening (NIPS) Basic Information
9.10.2 Harmony Non-Invasive Prenatal Screening (NIPS) Product Overview
9.10.3 Harmony Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.10.4 Harmony Business Overview
9.10.5 Harmony Recent Developments
10 NON-INVASIVE PRENATAL SCREENING (NIPS) REGIONAL MARKET FORECAST
10.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast
10.2 Global Non-Invasive Prenatal Screening (NIPS) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country
10.2.3 Asia Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Region
10.2.4 South America Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Non-Invasive Prenatal Screening (NIPS) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Non-Invasive Prenatal Screening (NIPS) Market Forecast by Type (2025-2030)
11.2 Global Non-Invasive Prenatal Screening (NIPS) Market Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Non-Invasive Prenatal Screening (NIPS) Market Size Comparison by Region (M USD)
Table 5. Global Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) by Company (2019-2024)
Table 6. Global Non-Invasive Prenatal Screening (NIPS) Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Prenatal Screening (NIPS) as of 2022)
Table 8. Company Non-Invasive Prenatal Screening (NIPS) Market Size Sites and Area Served
Table 9. Company Non-Invasive Prenatal Screening (NIPS) Product Type
Table 10. Global Non-Invasive Prenatal Screening (NIPS) Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Non-Invasive Prenatal Screening (NIPS)
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Non-Invasive Prenatal Screening (NIPS) Market Challenges
Table 18. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Type (M USD)
Table 19. Global Non-Invasive Prenatal Screening (NIPS) Market Size (M USD) by Type (2019-2024)
Table 20. Global Non-Invasive Prenatal Screening (NIPS) Market Size Share by Type (2019-2024)
Table 21. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Type (2019-2024)
Table 22. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application
Table 23. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2019-2024) & (M USD)
Table 24. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Application (2019-2024)
Table 25. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Application (2019-2024)
Table 26. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2019-2024) & (M USD)
Table 27. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region (2019-2024)
Table 28. North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2019-2024) & (M USD)
Table 29. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2019-2024) & (M USD)
Table 31. South America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2019-2024) & (M USD)
Table 33. Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Basic Information
Table 34. Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 35. Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2019-2024)
Table 36. Myriad Genetics Non-Invasive Prenatal Screening (NIPS) SWOT Analysis
Table 37. Myriad Genetics Business Overview
Table 38. Myriad Genetics Recent Developments
Table 39. Illumina Non-Invasive Prenatal Screening (NIPS) Basic Information
Table 40. Illumina Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 41. Illumina Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2019-2024)
Table 42. Myriad Genetics Non-Invasive Prenatal Screening (NIPS) SWOT Analysis
Table 43. Illumina Business Overview
Table 44. Illumina Recent Developments
Table 45. Progenity Non-Invasive Prenatal Screening (NIPS) Basic Information
Table 46. Progenity Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 47. Progenity Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2019-2024)
Table 48. Myriad Genetics Non-Invasive Prenatal Screening (NIPS) SWOT Analysis
Table 49. Progenity Business Overview
Table 50. Progenity Recent Developments
Table 51. Natera Non-Invasive Prenatal Screening (NIPS) Basic Information
Table 52. Natera Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 53. Natera Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2019-2024)
Table 54. Natera Business Overview
Table 55. Natera Recent Developments
Table 56. Yourgene Health Non-Invasive Prenatal Screening (NIPS) Basic Information
Table 57. Yourgene Health Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 58. Yourgene Health Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2019-2024)
Table 59. Yourgene Health Business Overview
Table 60. Yourgene Health Recent Developments
Table 61. Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Basic Information
Table 62. Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 63. Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2019-2024)
Table 64. Roche Sequencing Solutions (RSS) Business Overview
Table 65. Roche Sequencing Solutions (RSS) Recent Developments
Table 66. Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Basic Information
Table 67. Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 68. Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2019-2024)
Table 69. Eurofins LifeCodexx GmbH Business Overview
Table 70. Eurofins LifeCodexx GmbH Recent Developments
Table 71. Labcorp Non-Invasive Prenatal Screening (NIPS) Basic Information
Table 72. Labcorp Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 73. Labcorp Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2019-2024)
Table 74. Labcorp Business Overview
Table 75. Labcorp Recent Developments
Table 76. PerkinElmer Non-Invasive Prenatal Screening (NIPS) Basic Information
Table 77. PerkinElmer Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 78. PerkinElmer Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2019-2024)
Table 79. PerkinElmer Business Overview
Table 80. PerkinElmer Recent Developments
Table 81. Harmony Non-Invasive Prenatal Screening (NIPS) Basic Information
Table 82. Harmony Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 83. Harmony Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2019-2024)
Table 84. Harmony Business Overview
Table 85. Harmony Recent Developments
Table 86. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Region (2025-2030) & (M USD)
Table 87. North America Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country (2025-2030) & (M USD)
Table 88. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country (2025-2030) & (M USD)
Table 89. Asia Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Region (2025-2030) & (M USD)
Table 90. South America Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country (2025-2030) & (M USD)
Table 91. Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country (2025-2030) & (M USD)
Table 92. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Type (2025-2030) & (M USD)
Table 93. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Non-Invasive Prenatal Screening (NIPS) Market Size Comparison by Region (M USD)
Table 5. Global Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) by Company (2019-2024)
Table 6. Global Non-Invasive Prenatal Screening (NIPS) Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Prenatal Screening (NIPS) as of 2022)
Table 8. Company Non-Invasive Prenatal Screening (NIPS) Market Size Sites and Area Served
Table 9. Company Non-Invasive Prenatal Screening (NIPS) Product Type
Table 10. Global Non-Invasive Prenatal Screening (NIPS) Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Non-Invasive Prenatal Screening (NIPS)
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Non-Invasive Prenatal Screening (NIPS) Market Challenges
Table 18. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Type (M USD)
Table 19. Global Non-Invasive Prenatal Screening (NIPS) Market Size (M USD) by Type (2019-2024)
Table 20. Global Non-Invasive Prenatal Screening (NIPS) Market Size Share by Type (2019-2024)
Table 21. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Type (2019-2024)
Table 22. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application
Table 23. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2019-2024) & (M USD)
Table 24. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Application (2019-2024)
Table 25. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Application (2019-2024)
Table 26. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2019-2024) & (M USD)
Table 27. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region (2019-2024)
Table 28. North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2019-2024) & (M USD)
Table 29. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2019-2024) & (M USD)
Table 31. South America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2019-2024) & (M USD)
Table 33. Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Basic Information
Table 34. Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 35. Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2019-2024)
Table 36. Myriad Genetics Non-Invasive Prenatal Screening (NIPS) SWOT Analysis
Table 37. Myriad Genetics Business Overview
Table 38. Myriad Genetics Recent Developments
Table 39. Illumina Non-Invasive Prenatal Screening (NIPS) Basic Information
Table 40. Illumina Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 41. Illumina Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2019-2024)
Table 42. Myriad Genetics Non-Invasive Prenatal Screening (NIPS) SWOT Analysis
Table 43. Illumina Business Overview
Table 44. Illumina Recent Developments
Table 45. Progenity Non-Invasive Prenatal Screening (NIPS) Basic Information
Table 46. Progenity Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 47. Progenity Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2019-2024)
Table 48. Myriad Genetics Non-Invasive Prenatal Screening (NIPS) SWOT Analysis
Table 49. Progenity Business Overview
Table 50. Progenity Recent Developments
Table 51. Natera Non-Invasive Prenatal Screening (NIPS) Basic Information
Table 52. Natera Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 53. Natera Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2019-2024)
Table 54. Natera Business Overview
Table 55. Natera Recent Developments
Table 56. Yourgene Health Non-Invasive Prenatal Screening (NIPS) Basic Information
Table 57. Yourgene Health Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 58. Yourgene Health Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2019-2024)
Table 59. Yourgene Health Business Overview
Table 60. Yourgene Health Recent Developments
Table 61. Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Basic Information
Table 62. Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 63. Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2019-2024)
Table 64. Roche Sequencing Solutions (RSS) Business Overview
Table 65. Roche Sequencing Solutions (RSS) Recent Developments
Table 66. Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Basic Information
Table 67. Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 68. Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2019-2024)
Table 69. Eurofins LifeCodexx GmbH Business Overview
Table 70. Eurofins LifeCodexx GmbH Recent Developments
Table 71. Labcorp Non-Invasive Prenatal Screening (NIPS) Basic Information
Table 72. Labcorp Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 73. Labcorp Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2019-2024)
Table 74. Labcorp Business Overview
Table 75. Labcorp Recent Developments
Table 76. PerkinElmer Non-Invasive Prenatal Screening (NIPS) Basic Information
Table 77. PerkinElmer Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 78. PerkinElmer Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2019-2024)
Table 79. PerkinElmer Business Overview
Table 80. PerkinElmer Recent Developments
Table 81. Harmony Non-Invasive Prenatal Screening (NIPS) Basic Information
Table 82. Harmony Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 83. Harmony Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2019-2024)
Table 84. Harmony Business Overview
Table 85. Harmony Recent Developments
Table 86. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Region (2025-2030) & (M USD)
Table 87. North America Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country (2025-2030) & (M USD)
Table 88. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country (2025-2030) & (M USD)
Table 89. Asia Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Region (2025-2030) & (M USD)
Table 90. South America Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country (2025-2030) & (M USD)
Table 91. Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country (2025-2030) & (M USD)
Table 92. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Type (2025-2030) & (M USD)
Table 93. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Industrial Chain of Non-Invasive Prenatal Screening (NIPS)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Non-Invasive Prenatal Screening (NIPS) Market Size (M USD), 2019-2030
Figure 5. Global Non-Invasive Prenatal Screening (NIPS) Market Size (M USD) (2019-2030)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Non-Invasive Prenatal Screening (NIPS) Market Size by Country (M USD)
Figure 10. Global Non-Invasive Prenatal Screening (NIPS) Revenue Share by Company in 2023
Figure 11. Non-Invasive Prenatal Screening (NIPS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Non-Invasive Prenatal Screening (NIPS) Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Type
Figure 15. Market Size Share of Non-Invasive Prenatal Screening (NIPS) by Type (2019-2024)
Figure 16. Market Size Market Share of Non-Invasive Prenatal Screening (NIPS) by Type in 2022
Figure 17. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Application
Figure 20. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Application (2019-2024)
Figure 21. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Application in 2022
Figure 22. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Application (2019-2024)
Figure 23. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region (2019-2024)
Figure 24. North America Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Country in 2023
Figure 26. U.S. Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada Non-Invasive Prenatal Screening (NIPS) Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico Non-Invasive Prenatal Screening (NIPS) Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Country in 2023
Figure 31. Germany Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region in 2023
Figure 38. China Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (M USD)
Figure 44. South America Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Country in 2023
Figure 45. Brazil Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 56. Global Non-Invasive Prenatal Screening (NIPS) Market Share Forecast by Type (2025-2030)
Figure 57. Global Non-Invasive Prenatal Screening (NIPS) Market Share Forecast by Application (2025-2030)
Figure 1. Industrial Chain of Non-Invasive Prenatal Screening (NIPS)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Non-Invasive Prenatal Screening (NIPS) Market Size (M USD), 2019-2030
Figure 5. Global Non-Invasive Prenatal Screening (NIPS) Market Size (M USD) (2019-2030)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Non-Invasive Prenatal Screening (NIPS) Market Size by Country (M USD)
Figure 10. Global Non-Invasive Prenatal Screening (NIPS) Revenue Share by Company in 2023
Figure 11. Non-Invasive Prenatal Screening (NIPS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Non-Invasive Prenatal Screening (NIPS) Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Type
Figure 15. Market Size Share of Non-Invasive Prenatal Screening (NIPS) by Type (2019-2024)
Figure 16. Market Size Market Share of Non-Invasive Prenatal Screening (NIPS) by Type in 2022
Figure 17. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Application
Figure 20. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Application (2019-2024)
Figure 21. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Application in 2022
Figure 22. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Application (2019-2024)
Figure 23. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region (2019-2024)
Figure 24. North America Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Country in 2023
Figure 26. U.S. Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada Non-Invasive Prenatal Screening (NIPS) Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico Non-Invasive Prenatal Screening (NIPS) Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Country in 2023
Figure 31. Germany Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region in 2023
Figure 38. China Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (M USD)
Figure 44. South America Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Country in 2023
Figure 45. Brazil Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 56. Global Non-Invasive Prenatal Screening (NIPS) Market Share Forecast by Type (2025-2030)
Figure 57. Global Non-Invasive Prenatal Screening (NIPS) Market Share Forecast by Application (2025-2030)
